Boston Scientific Corporation (BSX) News
Track canonical SquawkNews coverage tagged to BSX, Boston Scientific Corporation. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 60 indexed stories across 25 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Citigroup cuts Boston Scientific price target to $50
Citigroup lowered its Boston Scientific price target to $50.00 from $57.00.
EQUITY | Sep 17, 2026, 01:39 PM UTC
H
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets.On Friday, the Do
NEWS | Sep 13, 2026, 01:11 PM UTC
M
US session market picture: S&P 500 +0.91%, Nasdaq 100 +0.98%; EUR/USD -0.1%, WTI -1.92%, KVUE leads volume
US session market picture. US index futures: S and P futures is up 0.91 percent, Nasdaq futures is up 0.98 percent, Dow futures is up 0.95 percent and Russell futures is up 0.48 percent. In currencies, the dollar index i
EQUITY | Sep 11, 2026, 07:30 PM UTC
M
US session market picture: S&P 500 +0.92%, Nasdaq 100 +1.02%; EUR/USD -0.11%, WTI -1.88%, KVUE leads volume
US session market picture. US index futures: S and P futures is up 0.92 percent, Nasdaq futures is up 1.02 percent, Dow futures is up 0.97 percent and Russell futures is up 0.54 percent. In currencies, the dollar index i
EQUITY | Sep 11, 2026, 07:02 PM UTC
L
Insiders buy Boston Scientific, Cardinal Infrastructure, GBank, Amrize shares
The article says insiders are buying shares at Boston Scientific, Cardinal Infrastructure Group, GBank Financial Holdings and Amrize after sharp stock declines. It highlights large open-market purchases by Boston Scienti
EQUITY | Sep 10, 2026, 04:16 PM UTC
M
Boston Scientific restores manufacturing, order fulfillment and shipping operations
Boston Scientific said it has restored its manufacturing, order fulfillment and shipping operations after last month's cyberattack. The company late Wednesday said products are moving through its distribution network at
EQUITY | Sep 10, 2026, 03:18 PM UTC
M
BSX says operations fully recovered from cyber attack
Boston Scientific (BSX) said operations have fully recovered from a global cyber attack. The company added that its Q3 and full-year financial guidance will not be met.
EQUITY | Sep 10, 2026, 01:29 PM UTC
H
BSX: Restored operations post-cyber attack, with new launches and acquisitions set to drive future growth
Operations and IT systems were fully restored after a global cyber attack, but financial guidance for Q3 and the full year is unlikely to be met. WATCHMAN faces market headwinds and new competition, while EP share erosio
MNA | Sep 10, 2026, 12:54 PM UTC
H
Boston Scientific likely misses guidance after August cyberattack disruption
Boston Scientific said it likely won’t meet its financial guidance due to the August cyberattack, which has disrupted medical-device manufacturing and shipping. Operations aren’t fully restored; the company expects to fa
EARNINGS | Sep 09, 2026, 11:44 AM UTC
L
Boston Scientific maintained at Buy by BTIG
Boston Scientific ratings action: BTIG maintained the stock at Buy.
EQUITY | Sep 09, 2026, 11:32 AM UTC
H
Boston Scientific says cyberattack will hit 2026 guidance
Boston Scientific said an August cybersecurity incident disrupted global operations and is expected to prevent the company from meeting previously issued third-quarter and full-year 2026 net sales and earnings guidance.
EARNINGS | Sep 08, 2026, 05:17 PM UTC
H
Boston Scientific cuts full-year targets after cyberattack order disruption
Boston Scientific said it is unlikely to meet full-year sales growth and earnings expectations, citing a major cyberattack disclosed last month that left it unable to fill orders. Shares fell more than 4% Tuesday morning
EARNINGS | Sep 08, 2026, 03:43 PM UTC
H
Boston Scientific shares fall after FY26/Q3 guidance outlook cut
Boston Scientific said it is unlikely to meet FY26 and Q3 adjusted EPS and net sales growth guidance after a previously announced cybersecurity incident affected operations.
EARNINGS | Sep 08, 2026, 02:37 PM UTC
H
Boston Scientific warns it may miss guidance after cyberattack
Boston Scientific said management is unlikely to hit quarterly and full-year guidance targets as fallout from a cyberattack in late August affects its financial results.
EARNINGS | Sep 08, 2026, 01:56 PM UTC
H
Boston Scientific says cyberattack may disrupt guidance delivery
Boston Scientific said it likely won’t meet its financial guidance due to a cyberattack that has disrupted operations, with shares down sharply in premarket trading.
EQUITY | Sep 08, 2026, 11:02 AM UTC
L
Boston Scientific working to restore shipments after cyberattack
Boston Scientific says it is working to restore shipments after a cyberattack.
EQUITY | Aug 31, 2026, 03:01 PM UTC
H
Boston Scientific details global disruption after cybersecurity incident
Boston Scientific identified a cybersecurity incident that caused global operational disruptions, including delays in processing and shipping customer orders. The company says system access remains limited and the restor
EARNINGS | Aug 26, 2026, 06:17 PM UTC
L
Boston Scientific Stock Price Drops After Cyberattack Triggers Global Outage — WSJ
Boston Scientific Stock Price Drops After Cyberattack Triggers Global Outage — WSJ
EQUITY | Aug 26, 2026, 04:09 PM UTC
L
Boston Scientific Stock Drops After Cyberattack — WSJ
Boston Scientific Stock Drops After Cyberattack — WSJ
EQUITY | Aug 26, 2026, 03:28 PM UTC
L
Boston Scientific Stock Is Falling as Cyberattack Puts More Strain on the Medical Device Maker — Barrons.com
Boston Scientific Stock Is Falling as Cyberattack Puts More Strain on the Medical Device Maker — Barrons.com
EQUITY | Aug 26, 2026, 01:59 PM UTC
L
Boston Scientific cyberattack disrupts global operations
Boston Scientific says a cyberattack is disrupting its global operations, according to TradingView News.
EQUITY | Aug 26, 2026, 11:27 AM UTC
M
Insiders Buy AAT, BBBY, BSX, CCB, GBFH, NMM, ONMD Shares
Insiders purchase shares in multiple companies
EQUITY | Aug 09, 2026, 06:19 PM UTC
H
Insiders Buy $13M+ in BSX, HLI, IR, PFE, WCC, TLSA, TSCO
Insiders purchase over $13 million in company shares
EQUITY | Aug 06, 2026, 09:19 AM UTC
L
Boston Scientific Director Sells 1,182 Shares
Director Habiger sells shares worth $56,887
EQUITY | Aug 05, 2026, 08:17 PM UTC
M
Insiders Buy BSX, HOG, HUN, PRQR, ACI Shares
Insiders purchase shares of various companies
EQUITY | Aug 03, 2026, 09:52 PM UTC
H
BSX Downgraded to Hold at Argus
Argus downgrades BSX to Hold
EQUITY | Jul 31, 2026, 11:55 AM UTC
H
PEN BSX - Penumbra, Inc. Reports Second Quarter 2026 Financial Results
PEN BSX - Penumbra, Inc. Reports Second Quarter 2026 Financial Results
EARNINGS | Jul 30, 2026, 08:05 PM UTC
H
BSX PT cut to $60 at Mizuho
Mizuho cuts BSX price target
EQUITY | Jul 30, 2026, 12:55 PM UTC
H
BSX PT Cut to $57
BSX price target reduced
EQUITY | Jul 30, 2026, 12:44 PM UTC
H
BSX: RBC Cuts Price Target
RBC cuts BSX price target to $70
EQUITY | Jul 30, 2026, 09:16 AM UTC
L
Largest premium to VWAP CSGP (+6.54%) LAD (+5.06%) GLOB (+4.66%) EXLS (+4.43%) GRMN (+4.4%) BSX (+3.49%) CLVT (+3.06%) DXC (+2.54%) CTSH (+2
Largest premium to VWAP CSGP (+6.54%) LAD (+5.06%) GLOB (+4.66%) EXLS (+4.43%) GRMN (+4.4%) BSX (+3.49%) CLVT (+3.06%) DXC (+2.54%) CTSH (+2.36%) HUBS (+2.32%) (Russell 1000 names)
EQUITY | Jul 29, 2026, 04:39 PM UTC
H
Boston Scientific Cuts Forecast on Product Slowdown and Competition
Boston Scientific Corporation (NYSE: BSX ) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets. Q2 Beats Estimates The medical technology giant reported r
EARNINGS | Jul 29, 2026, 03:12 PM UTC
L
BSX Boston Scientific exec notes Co expects its electrophysiology business to improve "nicely" in h2 2027
BSX Boston Scientific exec notes Co expects its electrophysiology business to improve "nicely" in h2 2027
RATES | Jul 29, 2026, 12:41 PM UTC
H
Boston Scientific Updates Forecast
Boston Scientific updates forecast for H2 2026
EQUITY | Jul 29, 2026, 12:22 PM UTC
L
BSX Boston Scientific exec notes second half watchman revenue is expected to decline at a mid- to high-single-digit rate year over year
BSX Boston Scientific exec notes second half watchman revenue is expected to decline at a mid- to high-single-digit rate year over year
RATES | Jul 29, 2026, 12:18 PM UTC
H
BSX Boston Scientific exec notes Co now expects global watchman sales growth to be flat to low single digits in 2026
BSX Boston Scientific exec notes Co now expects global watchman sales growth to be flat to low single digits in 2026
EARNINGS | Jul 29, 2026, 12:17 PM UTC
H
Boston Scientific Sees EPS, Revenue Growth Improving
Boston Scientific expects EPS and revenue growth to improve
EARNINGS | Jul 29, 2026, 12:09 PM UTC
H
BSX sharp reversal after results, now down -6% after rising more than 8% first
BSX sharp reversal after results, now down -6% after rising more than 8% first
EARNINGS | Jul 29, 2026, 12:09 PM UTC
H
Boston Scientific Sees H2 2026 Pressured
Boston Scientific expects H2 2026 to be more pressured
EQUITY | Jul 29, 2026, 12:08 PM UTC
H
BSX premarket hi;s +8% after results
BSX premarket hi;s +8% after results
EARNINGS | Jul 29, 2026, 10:50 AM UTC
H
Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36 Est; Lowers FY2026 Sales Guidance from $21.479B-$2
Boston Scientific (NYSE: BSX ) lowers FY2026 Adj EPS guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36 analyst estimate. Lowers FY2026 sales outlook from $21.479 billion-$21.780 billion to $21.178 billion-$21.379 billion
EARNINGS | Jul 29, 2026, 10:32 AM UTC
H
Boston Scientific Q2 Net Income $905M
Boston Scientific beats Q2 revenue estimates
EARNINGS | Jul 29, 2026, 10:31 AM UTC
H
BSX - Boston Scientific announces results for second quarter 2026
BSX - Boston Scientific announces results for second quarter 2026
EARNINGS | Jul 29, 2026, 10:31 AM UTC
H
BSX Boston Scientific RESULTS: Q2, Q2 Net Income $905M, Q2 REV $5.442B vs. EST $5.361B, Q2 EPS $0.61, Q2 ADJ EPS $0.86 vs. EST $0.83, Boston
BSX Boston Scientific RESULTS: Q2, Q2 Net Income $905M, Q2 REV $5.442B vs. EST $5.361B, Q2 EPS $0.61, Q2 ADJ EPS $0.86 vs. EST $0.83, Boston Scientific Earnings Notes:, Outlook FY organic REV growth 5-6%, Outlook FY ADJ
EARNINGS | Jul 29, 2026, 10:30 AM UTC
H
Implied EPS movers for tomorrow AM: PG +/-3.4%, APH +/-11.5%, VRT +/-11.2%, ADP +/-5.0%, FLEX +/-20.8%, SOFI +/-8.5%, BSX +/-7.1%, HUM +/-7.
Implied EPS movers for tomorrow AM: PG +/-3.4%, APH +/-11.5%, VRT +/-11.2%, ADP +/-5.0%, FLEX +/-20.8%, SOFI +/-8.5%, BSX +/-7.1%, HUM +/-7.8%, GD +/-3.7%, TEVA +/-6.5%, JCI +/-7.8%, CTSH +/-11.7%, ODFL +/-8.3%, ETR +/-4
EARNINGS | Jul 28, 2026, 06:05 PM UTC
H
BSX Earnings pre-market tomorrow: qtr EPS est $0.83 (high $0.84/low $0.80), 30-day avg EPS revision -0.7% (1 analyst(s) revised up, 3 down),
BSX Earnings pre-market tomorrow: qtr EPS est $0.83 (high $0.84/low $0.80), 30-day avg EPS revision -0.7% (1 analyst(s) revised up, 3 down), qtr revs est $5.36B; FY EPS est $3.36, FY revs est $21.56B; short interest 1.9%
EARNINGS | Jul 28, 2026, 04:12 PM UTC
L
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
EQUITY | Jul 28, 2026, 11:47 AM UTC
L
BSX Boston Scientific Corp - estimates $700M-$800M pre-tax charges, $500M annual pre-tax expense reduction - SEC filing
BSX Boston Scientific Corp - estimates $700M-$800M pre-tax charges, $500M annual pre-tax expense reduction - SEC filing
REGULATION | Jul 27, 2026, 08:08 PM UTC
L
BSX Boston Scientific Corp - approves 2026 global restructuring plan on July 21 - SEC filing - Company expects headcount reductions from res
BSX Boston Scientific Corp - approves 2026 global restructuring plan on July 21 - SEC filing - Company expects headcount reductions from restructuring - SEC filing
REGULATION | Jul 27, 2026, 08:08 PM UTC
L
BSX Lowering EP/Watchman estimates given continued competitive pressures & recent company commentary; lower PT to $85 from $90 @ OPCO
BSX Lowering EP/Watchman estimates given continued competitive pressures & recent company commentary; lower PT to $85 from $90 @ OPCO
EQUITY | Jul 27, 2026, 12:49 PM UTC
L
Boston Scientific recommending some percutaneous catheters be removed, FDA says
CDRH is issuing and...
EQUITY | Jul 24, 2026, 07:33 PM UTC
L
BSX little roll after FDA Early Alert: Percutaneous Catheter Issue from Boston Scientific Early Alert: Percutaneous Catheter Issue from Bost
BSX little roll after FDA Early Alert: Percutaneous Catheter Issue from Boston Scientific Early Alert: Percutaneous Catheter Issue from Boston Scientific
REGULATION | Jul 24, 2026, 07:32 PM UTC
M
SPY Next week roughly 1/3 of the S&P 500 is expected to report led by Industrials, Financials and Tech: Tuesday 7/27 top names: KO GLW SPGI
SPY Next week roughly 1/3 of the S&P 500 is expected to report led by Industrials, Financials and Tech: Tuesday 7/27 top names: KO GLW SPGI BA KLAC V STX BE PYPL UPS RCL CNC Wednesday 7/28: META MSFT HOOD ARM VRT GD PG A
RATES | Jul 24, 2026, 05:13 PM UTC
L
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
EQUITY | Jul 21, 2026, 12:24 PM UTC
L
AIV BSX FMC LVS OKLO PNR among names hitting 52-week lows today
AIV BSX FMC LVS OKLO PNR among names hitting 52-week lows today
EQUITY | Jul 15, 2026, 04:45 PM UTC
H
Other names lower after HCA results, guidance: ISRG -6% BSX -5% ZBH -6% THC -6% UHS -5% CYH -5%
Other names lower after HCA results, guidance: ISRG -6% BSX -5% ZBH -6% THC -6% UHS -5% CYH -5%
EARNINGS | Jul 14, 2026, 03:24 PM UTC
H
Boston Scientific put volume heavy and directionally bearish
Bearish flow noted in Boston Scientific with 6,918 puts trading, or 1.8x expected. Most active are Jul-26 43 puts and Jul-26 42.5 puts, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 6.22,
EQUITY | Jul 06, 2026, 02:15 PM UTC
M
BSX: Stifel Maintains Buy
Stifel analyst Rick Wise maintains Boston Scientific with a Buy and lowers the price target from $75 to $65
EQUITY | Jun 25, 2026, 03:34 PM UTC
M
BSX: Jefferies Lowers Target
Jefferies maintains Buy on Boston Scientific, lowers price target to $67
EQUITY | Jun 24, 2026, 06:10 PM UTC
M
Cramer Buys SOFI
Jim Cramer recommends buying SoFi Technologies, citing its current price level as a good buying opportunity
EQUITY | Jun 22, 2026, 12:03 PM UTC